Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
UNIVERSIDAD DE VALLADOLID currently has 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These matters are distributed among 2 distinct examiners and 2 distinct art units. This distribution shows that the university is engaging with multiple points of review within the patent office simultaneously.
REYNOLDS, FRED H is the busiest examiner for the portfolio, with 1 pending office action. Because the university interacts with 2 distinct art units, the current prosecution effort involves different specialized sectors of biotechnology.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| REYNOLDS, FRED H | 1 | 32.9% | +39.3% |
| AUDET, MAURY A | 1 | 50.1% | +23.9% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17285935 | COMPOSITION BASED ON RECOMBINANT BIOPOLYMERS AND USES OF SAME AS BIO-INK | REYNOLDS, FRED H | — |
| 17279129 | TREATMENT OF MYOCARDIAL INFARCTION | AUDET, MAURY A | — |
| Art Unit | Apps |
|---|---|
| 1658 | 1 |
| 1654 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17285935 | COMPOSITION BASED ON RECOMBINANT BIOPOLYMERS AND USES OF SAME AS BIO-INK | REYNOLDS, FRED H | 1658 | §103 | Final Rejection | — | Pending | Oct 27, 2021 |
| 17279129 | TREATMENT OF MYOCARDIAL INFARCTION | AUDET, MAURY A | 1654 | §103 | Final Rejection | — | Pending | Mar 24, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUNIVERSIDAD DE VALLADOLID has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Fred H Reynolds has the most, with 1 of UNIVERSIDAD DE VALLADOLID's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
